Here's Why High Tide (CVE:HITI) Can Afford Some Debt
Sep 23
Canadian (TSX) Pharma Industry Analysis
UpdatedSep 26, 2023
DataAggregated Company Financials
Companies117
- 7D-9.2%
- 3M37.6%
- 1Y-23.5%
- YTD-2.5%
Over the last 7 days, the Pharma industry has dropped 9.2%, driven by a pullback from Curaleaf Holdings of 16%. On the other hand High Tide is actually up 12%. However, the industry is down 23% over the past year. As for the next few years, earnings are expected to grow by 83% per annum.
Industry Valuation and Performance
Has the Canadian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 26 Sep 2023 | CA$20.3b | CA$12.9b | -CA$7,879,381,525.00 | 13.9x | -2.6x | 1.6x |
| Thu, 24 Aug 2023 | CA$13.9b | CA$13.0b | -CA$8,056,604,126.00 | 15.5x | -1.7x | 1.1x |
| Sat, 22 Jul 2023 | CA$14.9b | CA$13.2b | -CA$9,710,742,156.00 | 12.2x | -1.5x | 1.1x |
| Mon, 19 Jun 2023 | CA$14.7b | CA$13.2b | -CA$9,390,780,770.00 | 12.5x | -1.6x | 1.1x |
| Wed, 17 May 2023 | CA$14.8b | CA$13.3b | -CA$10,213,275,744.00 | 10.1x | -1.4x | 1.1x |
| Fri, 14 Apr 2023 | CA$15.5b | CA$13.2b | -CA$9,924,561,603.00 | 10.1x | -1.6x | 1.2x |
| Sun, 12 Mar 2023 | CA$18.9b | CA$13.9b | -CA$10,628,254,814.00 | 8.7x | -1.8x | 1.4x |
| Tue, 07 Feb 2023 | CA$20.5b | CA$13.6b | -CA$10,158,056,415.00 | 11x | -2x | 1.5x |
| Thu, 05 Jan 2023 | CA$20.3b | CA$13.6b | -CA$10,117,950,152.00 | 13.4x | -2x | 1.5x |
| Sat, 03 Dec 2022 | CA$33.3b | CA$13.6b | -CA$10,188,493,690.00 | 16.8x | -3.3x | 2.5x |
| Mon, 31 Oct 2022 | CA$27.3b | CA$13.4b | -CA$9,379,847,292.00 | 8.9x | -2.9x | 2x |
| Wed, 28 Sep 2022 | CA$24.7b | CA$13.5b | -CA$9,408,449,706.00 | 11.2x | -2.6x | 1.8x |
| Fri, 26 Aug 2022 | CA$32.7b | CA$13.0b | -CA$8,945,641,541.00 | 13.1x | -3.7x | 2.5x |
| Sun, 24 Jul 2022 | CA$29.4b | CA$12.2b | -CA$5,866,752,238.00 | 11.6x | -5x | 2.4x |
| Tue, 21 Jun 2022 | CA$28.1b | CA$12.2b | -CA$5,809,126,081.00 | 8.2x | -4.8x | 2.3x |
| Thu, 19 May 2022 | CA$31.8b | CA$12.0b | -CA$5,663,879,448.00 | 9.6x | -5.6x | 2.6x |
| Sat, 16 Apr 2022 | CA$40.8b | CA$11.6b | -CA$4,671,784,119.00 | 12.3x | -8.7x | 3.5x |
| Mon, 14 Mar 2022 | CA$39.3b | CA$10.9b | -CA$4,382,393,107.00 | 12.4x | -9x | 3.6x |
| Wed, 09 Feb 2022 | CA$49.8b | CA$10.9b | -CA$4,913,249,538.00 | 12.9x | -10.1x | 4.6x |
| Fri, 07 Jan 2022 | CA$51.1b | CA$10.9b | -CA$4,962,809,644.00 | 13.3x | -10.3x | 4.7x |
| Sun, 05 Dec 2021 | CA$55.4b | CA$10.9b | -CA$4,789,068,487.00 | 14.8x | -11.6x | 5.1x |
| Tue, 02 Nov 2021 | CA$59.3b | CA$10.1b | -CA$4,801,163,875.00 | 15.9x | -12.4x | 5.9x |
| Thu, 30 Sep 2021 | CA$66.6b | CA$10.4b | -CA$4,904,507,546.00 | 18.7x | -13.6x | 6.4x |
| Sat, 28 Aug 2021 | CA$69.1b | CA$10.2b | -CA$6,616,236,433.27 | 21.4x | -10.4x | 6.8x |
| Sun, 04 Jul 2021 | CA$83.0b | CA$10.2b | -CA$6,613,771,569.27 | 24.2x | -12.5x | 8.1x |
| Wed, 07 Apr 2021 | CA$88.7b | CA$8.8b | -CA$7,557,962,787.40 | 23.8x | -11.7x | 10x |
| Sat, 09 Jan 2021 | CA$57.0b | CA$7.0b | -CA$8,796,767,091.19 | 25.1x | -6.5x | 8.1x |
| Fri, 02 Oct 2020 | CA$35.8b | CA$6.4b | -CA$10,187,973,751.03 | 24.5x | -3.5x | 5.6x |
Price to Earnings Ratio
-3.5x
Current Industry PE
- Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.6x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 27% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | -3.00% | |
| Healthcare | -6.25% | |
| Pharma | -9.17% | |
| Pharma | -9.17% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HITI High Tide | CA$2.76 | 11.7% +CA$21.8m | 44.5% | PS0.4x | |
| DMT Small Pharma | CA$0.19 | 40.7% +CA$17.8m | 26.7% | PB5.1x | |
| EPIC 1CM | CA$2.00 | 3.6% +CA$8.0m | 38.9% | PS9.6x | |
| HLS HLS Therapeutics | CA$5.19 | 3.8% +CA$6.1m | -40.5% | PS2x | |
| GRIN Grown Rogue International | CA$0.34 | 8.1% +CA$4.6m | 318.8% | PE38.4x |
